This study is attempting to define the optimal treatment for subclavian vein thrombosis complicating indwelling catheters. Patient will receive thrombolytic therapy with tissue plasminogen activator to define the preferred dose and duration of therapy for this clinical indication. Preventative therapy with low dose coumadin or adjusted dose heparin will be compared in those patients achieving clot lysis.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010193-04
Application #
3774505
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code